Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 23.52B | 34.35B | 31.76B | 30.41B | 25.76B | 22.52B |
Gross Profit | 8.19B | 12.27B | 10.87B | 10.05B | 8.45B | 7.41B |
EBITDA | 4.19B | 6.88B | 5.47B | 5.00B | 4.50B | 3.21B |
Net Income | 1.70B | 3.34B | 2.87B | 3.63B | 2.26B | 915.86M |
Balance Sheet | ||||||
Total Assets | 53.98B | 50.61B | 47.47B | 45.19B | 44.67B | 44.94B |
Cash, Cash Equivalents and Short-Term Investments | 2.88B | 3.88B | 6.33B | 5.94B | 5.78B | 7.72B |
Total Debt | 17.16B | 15.31B | 13.02B | 10.96B | 12.16B | 13.85B |
Total Liabilities | 30.35B | 27.76B | 25.85B | 22.85B | 23.76B | 24.60B |
Stockholders Equity | 22.34B | 21.61B | 20.85B | 21.69B | 20.23B | 19.66B |
Cash Flow | ||||||
Free Cash Flow | 1.11B | 2.37B | 2.95B | 2.15B | 2.37B | 2.43B |
Operating Cash Flow | 3.17B | 4.86B | 4.60B | 3.56B | 3.74B | 3.24B |
Investing Cash Flow | -3.38B | -6.12B | -2.21B | -885.59M | -2.27B | -893.82M |
Financing Cash Flow | 56.42M | -1.15B | -2.16B | -2.32B | -2.91B | 234.27M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | £76.86B | 23.88 | 15.22% | 1.29% | 3.85% | -0.93% | |
78 Outperform | $37.21B | 34.19 | 12.10% | 0.51% | 1.02% | -45.31% | |
76 Outperform | $38.47B | 40.58 | 11.89% | 0.66% | 0.19% | 4.33% | |
75 Outperform | $13.55B | 8.74 | 7.12% | 0.93% | -9.62% | 795.20% | |
74 Outperform | $7.70B | 17.47 | 31.87% | 0.43% | 0.88% | -4.17% | |
63 Neutral | $5.11B | 30.77 | 11.11% | ― | 2.64% | -22.49% | |
61 Neutral | $10.31B | 6.29 | 0.76% | 2.95% | 3.36% | -36.41% |